1h Free Analyst Time
The artificial organs market is forecasted to grow by USD 14.85 billion during 2023-2028, accelerating at a CAGR of 9.49% during the forecast period. The report on the artificial organs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of chronic disorders, shortage of organ donors, and growing demand for pacemakers and dialyzers.
The artificial organs market is segmented as below:
By Usage
- Implantable
- Extracorporeal
By Product
- Artificial heart
- Artificial kidney
- Cochlear implants
- Artificial pancreas
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the artificial organs market covers the following areas:
- Artificial organs market sizing
- Artificial organs market forecast
- Artificial organs market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. IT presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Usage
7 Market Segmentation by Product
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global artificial organs market: Abbott Laboratories, Asahi Kasei Corp., B.Braun SE, Baxter International Inc., BioTelemetry Inc., BIOTRONIK SE and Co. KG, BiVACOR Inc., Boston Scientific Corp., Cochlear Ltd., F. Hoffmann La Roche Ltd., Fresenius Medical Care AG and Co. KGaA, Insulet Corp., MED EL Elektromedizinische Gerate GmbH, Medtronic Plc, Nihon Kohden Corp., Nikkiso Co. Ltd., Nipro Corp., Sonova AG, SynCardia Systems LLC, and Tandem Diabetes Care Inc..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is emergence of tah."
According to the report, one of the major drivers for this market is the increasing prevalence of chronic disorders.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Laboratories
- Asahi Kasei Corp.
- B.Braun SE
- Baxter International Inc.
- BioTelemetry Inc.
- BIOTRONIK SE and Co. KG
- BiVACOR Inc.
- Boston Scientific Corp.
- Cochlear Ltd.
- F. Hoffmann La Roche Ltd.
- Fresenius Medical Care AG and Co. KGaA
- Insulet Corp.
- MED EL Elektromedizinische Gerate GmbH
- Medtronic Plc
- Nihon Kohden Corp.
- Nikkiso Co. Ltd.
- Nipro Corp.
- Sonova AG
- SynCardia Systems LLC
- Tandem Diabetes Care Inc.
